PIK3CA-related overgrowth spectrum (PROS) encompasses different clinical entities caused by somatic activating mutations in PIK3CA. Among PROS, CLOVES syndrome represents a severe phenotype with poor survival rate. We present the case of a 4-month-old girl with CLOVES syndrome successfully treated with alpelisib, a PIKC3A inhibitor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pde.15582 | DOI Listing |
Publication Analysis
Top Keywords
pik3ca-related overgrowth
8
overgrowth spectrum
8
cloves syndrome
8
four-month-old severe
4
severe pik3ca-related
4
spectrum disorder
4
disorder treated
4
treated alpelisb
4
alpelisb pik3ca-related
4
spectrum pros
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!